PATENT CLAIM ANALYSIS

Application Number: 15746335
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "007100"]

Abstract:
The invention provides a process for analysis of the presence of atherosclerosis in a patient sample, and preferably identifies a form of atherosclerosis that correlates to an increased risk of the patient to develop rheumatoid arthritis (RA), connective tissue diseases, vasculitis, and/or spondyloarthritis, and/or myocardial infarction and/or apoplexy.

Claim (Index 2):
Process according to  claim 1 , wherein an elevated concentration of anti-MAZI auto-antibody is indicative of atherosclerosis and/or of an increased risk for myocardial infarction and/or of an increased risk for apoplexy.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.36585
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14261843', '12376164', '12681349', '13613010', '14116924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5943509859080599
- 35 USC 102 Novelty (BERT): 0.4942163560727648
- Combined Prediction Score: 0.5843375229245305
- Mean Citation Score: 200.499088
- Max Citation Score: 205.21992
- Similarity Product: 135.77371795738222

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test